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Abstract
Purpose—To conduct a comparative analysis of eight pediatric self-report scales for ages 8-17 
years from the National Institutes of Health (NIH) Patient Reported Outcomes Measurement 
Information System (PROMIS®) in six pediatric chronic health conditions, using indicators of 
disease severity.
Methods—Pediatric patients (N = 1,454) with asthma, cancer, chronic kidney disease, obesity, 
rheumatic disease, and sickle cell disease completed items from the PROMIS pediatric mobility, 
upper extremity functioning, depressive symptoms, anxiety, anger, peer relationships, pain 
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interference, and fatigue self-report scales. Comparisons within the six pediatric chronic health 
conditions were conducted by examining differences in groups based on disease severity using 
markers of severity that were specific to characteristics of each disease. A comparison was also 
made across diseases between children who had been recently hospitalized and those who had not.
Results—In general, there were differences in self-reported health outcomes within each chronic 
health condition, with patients who had higher disease severity showing worse outcomes. Across 
health conditions, when children with recent hospitalizations were compared with those who had 
not been hospitalized in the past six months, we found significant differences in the expected 
directions for all PROMIS domains, except anger.
Conclusions—PROMIS measures discriminate between different clinically meaningful 
subgroups within several chronic illnesses. Further research is needed to determine the 
responsiveness of the PROMIS pediatric scales to change over time.
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Introduction
The Patient Reported Outcomes Measurement Information System (PROMIS®) is a 
National Institutes of Health (NIH) initiative, created to advance the assessment of patient-
reported outcomes (PRO) in patients with chronic diseases. Over the past ten years, 
PROMIS has developed several pediatric self-report item banks for ages 8-17 years across 
five general health domains (physical function, pain, fatigue, emotional health, social health) 
consistent with the larger PROMIS network, and additional health domains will be released 
soon [1]. We anticipated that measures of these five general health domains would be 
applicable across pediatric chronic health conditions, and hence they were developed as 
general or nondisease-specific scales [2-8]. The PROMIS pediatric measures were 
developed using qualitative and quantitative methods, including focus groups, expert item 
review, cognitive interviewing, and item administration to a large population of children and 
adolescents to create banks of items specific to selected domains [2; 9; 10].
The majority of extant pediatric self-report scales, consistent with other clinical assessment 
instruments [11], have utilized Classical Test Theory (CTT) and have rarely taken advantage 
of item response theory (IRT) analysis in the scale development process [12]. By utilizing 
IRT analysis, the resulting item bank can be the basis of a more customizable measure for 
meeting a researcher's or clinician's needs. Depending on the desired level of precision, the 
user can select the number of items to administer and obtain scores on the same metric as all 
other users of the item bank [12].
The validity of a measurement instrument includes its ability to differentiate patients who 
are known to have different experiences. Studies have documented this known-group 
validity for other pediatric PRO instruments, such as the Peds QL, that were both general 
and disease-specific measures of HRQOL [13-18]. Performing these tests across several 
chronic illnesses supports the notion that PROMIS is a versatile measure applicable in many 
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different clinical situations. Each illness group and severity of illness within groups can have 
varied effects across different PRO domains. Documenting the different patters of PRO 
profiles can lead to a more nuanced understanding of chronic illnesses.
The objective of the present study is to describe the use of selected PROMIS pediatric self-
report scales in six common pediatric chronic health conditions: asthma, cancer, chronic 
kidney disease, obesity, rheumatic disease, and sickle cell disease. Within each group, we 
identified a marker of disease severity based on our available data and examined differences 
in patients' health outcomes between these groups. We hypothesized that PROMIS measures 
would be sensitive to differences in health status for all of the chronic health conditions. 
Moreover, we hypothesized that across disease groups, children with recent hospitalizations 
would show worse outcomes than those who had not been hospitalized in the past six 
months. The primary aim of this study is a test of the PROMIS instruments. Secondarily, we 
are able to get estimates of the latent traits and magnitudes of difference across the 
comparison groups. This adds comparative information for future PROMIS users.
Methods
Selection of Patient Samples
Data collection across the samples took place from 2009 to 2010. Participants were recruited 
from hospital-based general pediatric clinics, subspecialty clinics, and hospital inpatient 
units. Participants were identified through a review of medical records, clinic appointment 
rosters, or while in the clinic waiting rooms according to protocols approved by the 
institutional review boards (IRBs) at each of the participating institutions. The data in the 
present study include previously published data on three individual disease groups: cancer 
[19], incident nephrotic syndrome [20], and obesity [21]. However, comparisons for the 
other chronic illness groups and across health conditions have not been previously reported.
All participants were required to meet the following inclusion criteria: able to speak and 
read English; able to interact with a computer screen, keyboard, and mouse; and aged 8 
through 17 years. The exclusion criteria were children having any concurrent medical or 
psychiatric condition that might preclude participation in this study or cognitive or other 
impairment (e.g., visual) that would interfere with completing a self-administered computer-
based questionnaire. Parents signed an informed consent document and children signed an 
informed assent document. Table 1 presents the sociodemographic characteristics for each 
patient sample.
Asthma sample
Pediatric patients were recruited from outpatient general pediatrics and subspecialty clinics 
at the University of North Carolina at Chapel Hill and Children's Hospital at Scott and 
White in Texas. In addition to the general inclusion and exclusion criteria cited above, 
eligible patients had a physician diagnosis of asthma and were currently using asthma 
medication. In addition to the short forms of the general PROMIS pediatric measures of 
depressive symptoms, anxiety, anger, pain interference, peer relationships, fatigue, upper 
extremity functioning, and mobility (see Appendix Table 1), children with asthma 
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completed the Asthma Control Test (ACT) [22]. The ACT is commonly used clinically to 
distinguish different levels of asthma control. For the within-group comparison, children 
with asthma were classified as “good control” status or “poor control” status based on the 
scoring guidelines of the ACT [22]. A total of 137 patients with asthma participated. Two 
participants had missing scores for one of the PROMIS measures. One of the participants 
ended the survey early, so the missing score was the last measure in the survey.
Cancer sample
Pediatric patients were recruited from the Children's National Medical Center in 
Washington, DC; Nebraska Medical Center in Omaha, Nebraska; Children's Hospital Los 
Angeles in California; Palmetto Health Children's Hospital in Columbia, South Carolina; 
and Emory University in Atlanta, Georgia. In addition to the general inclusion and exclusion 
criteria cited above, eligible patients were currently receiving curative cancer treatment 
(defined as disease-directed therapy within the past 45 days) or had completed cancer 
treatment and were disease-free and in follow-up care (survivorship group). An additional 
exclusion criterion included patients who were receiving end-of-life care (defined as 
supportive treatment following a decision against resuscitation or favoring terminal care 
with possible hospice involvement). Participants completed the PROMIS pediatric measures 
of depressive symptoms, anxiety, anger, pain interference, peer relationships, fatigue, upper 
extremity functioning, and mobility (see Appendix Table 1). The within-group comparisons 
were made based on whether patients were in active treatment (defined as disease-directed 
therapy within the past 45 days) or had completed cancer treatment, were disease-free, and 
in follow-up care (survivorship group). A total of 200 patients participated. Sixteen (8%) 
had missing scores for at least 1 of the PROMIS measures. Thirteen of these 16 participants 
(6.5%) ended the survey early, so the missing measures were at the end of the survey [23].
Chronic kidney disease sample
Pediatric patients were recruited through the Midwest Pediatric Nephrology Consortium 
from 16 participating member institutions. In addition to the general inclusion and exclusion 
criteria cited above, eligible patients had to have physician confirmed chronic kidney 
disease, defined dialysis or kidney transplant dependence, estimated glomerular filtration 
rate (eGFR) < 90 ml/min/1.73m2, or nephrotic syndrome [24]. A lower eGFR represents 
worse kidney function, with eGFR ≤ 15 representing kidney failure. Participants completed 
the PROMIS measures of depressive symptoms, anxiety, pain interference, peer 
relationships, fatigue, and mobility (see Appendix Table 1).
For the within group comparisons, children with kidney disease were grouped based on their 
glomerular filtration rate (eGFR) < 90 ml/min/1.73m2. A lower eGFR represents worse 
kidney function, with eGFR ≤ 15 representing kidney failure. We grouped patients into 3 
categories that correspond to established stages of chronic kidney disease: 1. eGFR ≥ 60, 
which represents those with mild and normal GFR (Stages 1 and 2); 2. eGFR < 60 and ≥ 15 
(moderate and severe decreases in GFR; Stages 3 and 4); and 3. eGFR was < 15, which 
represents kidney failure and a need for dialysis or transplant (Stage 5). Patients who had 
already received kidney transplants were excluded from this analysis, as they are usually 
grouped into their own category but represent a range of health and functioning. In total, 384 
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children with chronic kidney disease participated in this study. A total of 13 children (3.4%) 
were missing one or more of the PROMIS domain scores. Twelve of the 13 patients with 
missing PROMIS scores ended the survey early.
Obesity sample
Pediatric patients were recruited from five participating sites including an academic obesity 
clinic, three private pediatric practices, and a federally qualified health center in North 
Carolina. In addition to the general inclusion and exclusion criteria cited above, eligible 
patients had an age adjusted body mass index (BMI) ≥ 85th percentile. Participants 
completed the PROMIS measures of depressive symptoms, anxiety, anger, pain interference, 
peer relationships, fatigue, upper extremity functioning, and mobility (see Appendix Table 
1). Patients with obesity were categorized into two groups: those with an age-adjusted BMI 
≥ 99th percentile and those with age-adjusted BMI <99th percentile. A total of 136 patients 
with obesity participated. Seven participants (5%) had missing scores for at least one of the 
PROMIS measures. Six of these seven participants ended the survey early, so measures 
administered at the end of the survey were missing responses.
Rheumatic disease sample
Patients with rheumatic disease were recruited from rheumatology clinics at four academic 
medical centers in California, North Carolina, Ohio, and Washington State. In addition to 
the general inclusion and exclusion criteria cited above, eligible patients had a physician-
confirmed diagnosis of juvenile idiopathic arthritis (JIA), childhood systemic lupus 
erythematosus (cSLE) or juvenile dermatomyositis (JDM) as well as some patients who had 
overlapping conditions. Participants were administered the following PROMIS measures: 
anger, anxiety, depressive symptoms, fatigue, pain interference, peer relationships, upper 
extremity functioning, and mobility (see Appendix Table 1). We also collected the 
Childhood Health Assessment Questionnaire (CHAQ) [25], parental ratings of children's 
overall well-being, numeric rating scale of average pain intensity over the past seven days, 
and school days missed due to illness.
For the within-group comparisons, patients were grouped by type of rheumatic disease (e.g., 
JIA, cSLE, or JDM). We also looked at number of school days missed as an indicator of 
disease severity. A total of 362 patients participated, 269 (74.3%) with JIA, 42 (11.6%) with 
cSLE, 23 (6.3%) with JDM, and 28 (7.7%) with overlapping conditions. Four participants 
(1.1%) had missing scores for at least one of the PROMIS measures. Three of these 
participants ended the survey early, 
Sickle cell disease sample
Pediatric patients were recruited from sickle cell disease programs at Emory University and 
Duke University. In addition to the general inclusion and exclusion criteria cited above, 
eligible patients had a physician diagnosis of sickle cell disease. Participants were recruited 
at clinic visits for routine care, hydroxyurea monitoring, or chronic transfusions. The 
hemoglobin genotypes were consistent with that of the general clinic population: SS 
(76.5%), SC (16.7%), Sickle B+ thalassemia (4.7%), and Sickle B0 thalassemia (1.3%). At 
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the time of the study, 19.1% of the participants were receiving chronic transfusions and 
45.5% were taking hydroxyurea.
Participants were administered the following domains: anger, anxiety, depressive symptoms, 
fatigue, pain interference, peer relationships, upper extremity functioning, and mobility (see 
Appendix Table 1). Researchers also collected frequency of hospital and emergency 
department visits for pain management, frequency of home pain management, and presence 
of hip or joint problems related to sickle cell disease. For the within group comparison, 
patients with sickle cell disease were categorized into two groups: those who had received 
home treatment for pain in the past week and those who had not. A total of 235 patients 
participated. Four participants (1.7%) had missing scores for at least one of the PROMIS 
measures. One of these participants ended the survey early, and the others missed a measure 
in the middle of the survey.
Pediatric self-report item banks
The PROMIS Pediatric item banks were developed using a strategic item generation 
methodology adopted by the PROMIS Network [26]. Six phases of item development were 
implemented: identification of existing items, item classification and selection, item review 
and revision, focus group input on domain coverage, cognitive interviews with individual 
items, and final revision before field testing. Because physical function includes both upper 
extremity functioning and mobility item banks and emotional distress includes anger, 
anxiety, and depressive symptoms item banks, for the present study, a total of 8 content 
domains were tested [2-8]. Participants were administered a combination of PROMIS Short 
Forms or complete item banks. Higher scores indicate more of the measured symptom being 
experienced, which signifies worse health for depression, anxiety, anger, fatigue, and pain 
interference and better health for mobility, upper extremity functioning, and peer 
relationships. For example, higher scores on the emotional distress scales indicate more 
(worse) emotional distress; higher scores on the physical functioning scales indicate higher 
(better) levels of physical functioning. All scales have recommended short forms with 8 
items, except fatigue (10 items) and anger (6 items), as previously described [2-8]. All items 
had a 7-day recall period and used standardized 5-point response options (e.g., never, almost 
never, sometimes, often, almost always; or, with no trouble, with a little trouble, with some 
trouble, with a lot of trouble, not able to do). The PROMIS Pediatrics T score of 50 was 
anchored as the mean of the calibration population, which was mixed with healthy children 
and chronically ill children. As such, the score of 50 does not represent any one group, but 
the same scoring metric is used for all applications, which allows for comparability across 
populations.
Statistical Analysis
Comparisons within and across chronic health conditions—Mean PROMIS 
scores within each pediatric chronic health condition category were compared using 
independent samples t-tests when two disease categories were being contrasted and Analysis 
of Variance (ANOVA) with Tukey post-hoc tests when more than 2 disease categories were 
being contrasted. The Tukey's post hoc tests were only utilized when there was a significant 
DeWalt et al. Page 6













omnibus ANOVA F-test. Given the exploratory nature of the study, we did not control for 
the number of statistical tests.
For the comparison of mean PROMIS scores across chronic health conditions, we used 
independent sample t-tests, as we divided the sample into two groups based on whether or 
not patients had been admitted to the hospital in the past six months (Yes/No categories).
Intercorrelations among the scale latent variables—Finally, intercorrelations 
among the latent variables for each of the eight PROMIS pediatric scales were estimated 
using the data from all of the chronic health conditions combined. Because the original 
development of the scales used a complex sampling design with the items spread across 
multiple forms [2-8], this is the first large sample with item response data for all scales; that 
makes this computation feasible. To estimate the latent correlations, we used the published 
item parameters as fixed values [2-8], as they are for computing IRT scores, to estimate the 
correlations among the latent variables directly. We used the Metropolis-Hastings Robbins-
Monro algorithm [27] as implemented in the software IRTPRO [28] to compute the latent 
variable covariances, and standardized those to obtain the correlations.
Results
Comparisons within chronic health conditions
Comparisons within chronic health conditions are in Table 2. Summaries of differences 
observed within each of the health conditions are provided below.
Pediatric asthma—Patients with good asthma control reported significantly higher 
(better) mobility and upper extremity functioning than patients with poor asthma control. 
Patients with poor asthma control reported significantly higher (worse) depressive 
symptoms, anxiety, anger, pain interference, and fatigue than patients with good asthma 
control.
Pediatric cancer—Pediatric survivors of childhood cancer reported significantly higher 
(better) mobility, upper extremity functioning, and peer relationships than patients on active 
cancer treatment. Pediatric patients on active cancer treatment reported significantly higher 
(worse) depressive symptoms, anxiety, pain interference, and fatigue than pediatric 
survivors of childhood cancer.
Pediatric chronic kidney disease—Patients with chronic kidney disease reported 
significant differences for physical functioning, including both mobility and upper extremity 
functioning, depending on the CKD stage. Specifically, patients with eGFR >15 reported 
better mobility and upper extremity functioning than patients with end stage kidney disease 
(eGFR ≤ 15). There were no significant differences between the CKD stages in the other 
domains. For the subset of patients with nephrotic syndrome (NS), patients with active NS 
(defined by the presence of edema) had lower mobility and higher anxiety, pain interference, 
and fatigue than those whose NS was not active.
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Pediatric obesity—Children with higher BMIs reported significantly lower mobility and 
higher anger and fatigue than patients with a BMI percentile < 99th.
Pediatric rheumatic disease—There were no significant differences across the domains 
between patients with Juvenile Dermatomyositis, Juvenile Idiopathic Arthritis, and Systemic 
Lupus Erythematosus. Given the heterogeneity of these groups, we also looked at number of 
school days missed as an indicator of disease severity. Patients with rheumatic disease who 
had missed three or more school days in the past six months reported lower mobility and 
higher pain interference and fatigue than patients who had missed zero to two school days.
Pediatric sickle cell disease—Patients who had been treated for pain reported lower 
mobility and upper extremity functioning and higher depressive symptoms, anxiety, pain 
interference, and fatigue than patients who had not.
Comparison across chronic health conditions
It was clear from the within-group comparisons that patients within each chronic health 
condition experienced a wide range of functioning and symptoms. Given the heterogeneity 
of these groups, we sought an indicator of disease severity that was administered to all 
groups in order to make across-group comparisons. We used a variable, parent-reported 
number of hospital admissions (e.g., overnight stays) in the past 6 months, as an indicator of 
disease severity. This item was administered to parents of children in four of the chronic 
illness groups: cancer, chronic kidney disease, rheumatic disease, and sickle cell disease.
Across the 4 chronic health conditions (N = 1136), 72.1% of the parents reported that their 
child had not been hospitalized in the past six months. Among those whose children had 
been hospitalized, 13.8% (n = 157) had been hospitalized one time; 6.1% (n = 69) had been 
hospitalized twice; 3.5% had been hospitalized three times; and the remaining 4.5% had 
been hospitalized four or more times in the past 6 months. For this analysis, patients were 
categorized into 2 groups, those who had not been hospitalized and those who had been 
hospitalized 1 or more times.
Patients who had been hospitalized in the past 6 months showed significantly worse 
functioning in all areas, except anger. They endorsed higher levels of depressive symptoms, 
anxiety, pain interference, and fatigue. In addition, they reported more problems in the areas 
of mobility, upper extremity functioning, and peer relationships (Table 3).
Correlations among the latent variables
Correlations among the latent variables are shown in Table 4. Some of the very highly 
correlated scales are among subdomain scores within domains. For example, the three 
emotional health scales (anger, anxiety, and depressive symptoms) were all correlated 
between 0.67 and 0.79, and the two physical functioning scales (upper extremity and 
mobility) were correlated 0.75. Fatigue was highly correlated with many other scales, over 
0.55 (in absolute value) with all of the other scales except peer relationships. Pain 
interference was correlated over 0.6 with mobility and around 0.6 with the emotional health 
scales. Peer relationships generally had the lowest correlations with the other scales.
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Our results demonstrate consistent differences across subgroups within particular chronic 
health conditions. Moreover, this study illustrates the importance of looking at subgroups 
within disease category rather than across diseases. It is very clear that scores in a disease 
category such as asthma will vary greatly depending on severity of disease and that a child 
with severe asthma is likely to look more like a child with severe symptoms of another 
disease than a child with mild asthma.
This study also demonstrates the usefulness of PROMIS instruments across a number of 
different diseases and measures of severity within diseases. Effects of disease status on 
mobility or anxiety can be assessed using general measures rather than attempts to attribute 
symptoms to an individual disease. Given that most patients have more than one disease, 
measures that are disease agnostic allow much more flexibility and interpretability. Below 
we discuss the chronic health-specific findings for each group in the context of the extant 
literature.
Pediatric asthma
Our findings are generally consistent with previous studies showing children with poor 
asthma control were more likely to experience lower functioning compared with children 
with good asthma control [29; 30]. Specifically, our study suggests that compared with 
participants with good asthma control, participants with poor asthma control had poorer 
mobility and upper extremity functioning; more depressive symptoms, anxiety and anger; 
and more somatic symptoms, including fatigue and pain.
Pediatric cancer
Our findings indicate significantly better scores for all indicators except anger for survivors 
compared with participants in active cancer treatment. This is consistent with other reports 
that long-term survivors of pediatric cancer experienced better physical health, psychosocial 
health, and emotional functioning than those undergoing treatment [13; 31]. Moreover, 
several studies have found that survivors of childhood cancer demonstrate positive 
psychological adjustment in areas such as life satisfaction, overall happiness, depression 
symptoms, anxiety, self-esteem, that are similar to and even superior to healthy, population 
norms [32-34]. There is some evidence that the experience of surviving cancer improves the 
individual's ability to cope and become more resilient, which helps to explain these findings 
[34; 35].
Pediatric chronic kidney disease
Similar to other disease groups in this study, different categories of illness within kidney 
disease reveal important differences in PROs. The present study identified that mobility and 
upper extremity functioning were worse in children with CKD who had lower eGFR. 
Previous reports of HRQOL in children with CKD have demonstrated variable results. In the 
US national Chronic Kidney Disease in Children study, worse HRQOL was demonstrated 
when compared with published normative controls in the domains of social, school, 
physical, and emotional functioning [36]. A subsequent study from the United Kingdom 
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evaluated children with CKD and demonstrated remarkably preserved HRQOL and 
suggested this perception of normal HRQOL may result from the subjective nature of self-
reported HRQOL [37].
Pediatric obesity
Results of this study are consistent with prior investigations of HRQOL among children with 
obesity. Obese children have demonstrated worse HRQOL in the domains of physical, 
emotional, social, and school functioning and fatigue when compared with healthy controls 
[38-40]. A recent meta-analysis derived from a total of 13,210 study participants 
demonstrated that based on self-reports, children and adolescents with above-normal BMI 
had significantly lower total, physical, and psychosocial HRQOL, with a clear dose 
relationship across all BMI categories [41]. Consistent with the literature, evaluations of 
functioning in children with BMI ≥ 99th percentile with the PROMIS scales showed that 
these children had worse scores in the depressive symptoms, anger, fatigue, and mobility 
domains relative to children with BMI from the 85th-99th percentiles.
Pediatric rheumatic disease
Studies of HRQOL in children with rheumatic disease have generally reported reduced 
HRQOL compared with healthy controls, most prominently in physical functioning [42-44]. 
When children with these conditions are evaluated according to disease activity or measures 
of severity, these findings are temporized. Ringold found the majority of children with the 
polyarticular form of JIA with inactive disease scored similarly to healthy children in all 
areas except fatigue [44]; children with JIA showed more fatigue. In a clinical sample of 941 
JIA patients, Seid and colleagues found that most patients had no or minimal symptoms 
according to four clinical measures, with only 7.9% of those patients having suboptimal 
scores on the PedsQL™ total score [43]. They further note that the majority of patients with 
mild symptoms have “optimal” HRQOL. Overall, participants in our study appeared to have 
low clinical impairment based on the CHAQ.
Pediatric sickle cell disease
The results from our study are consistent with the largest previous HRQOL study of children 
with SCD [45]. In that study, 1393 children were administered the self-report version (age 
ranges 5-7, 8-12, and 13-18) of the 23-item PedsQL™ 4.0 Generic Core Scales (physical, 
emotional, social and school functioning) and the 18-item PedsQL™ Multidimensional 
Fatigue Scale (General Fatigue, Sleep/Rest Fatigue, and Cognitive Fatigue) [45]. Children 
with 1-3 or ≥4 hospitalizations compared with those with no hospitalizations in the previous 
two years scored worse in all child-reported PedsQL™ functioning and fatigue scales. In our 
study, children with recent pain episodes had worse scores across several domains, including 
physical functioning, emotional distress, fatigue, and pain interference. The fact that having 
a recent need for treatment of pain was the defining characteristic of one group, we expected 
large differences for the pain interference domain.
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Correlations among the scales
This study reports, for the first time, estimates of the latent variables correlations among 
eight PROMIS pediatric scales. The patterns of intercorrelations are unsurprising, but they 
provide useful background information for investigators who plan to use several of the 
scales in their research; this large dataset, including participants from several chronic disease 
groups, provided more data for the computation of these correlations than will likely be 
available from many single-purpose studies. Adding these correlations to the literature 
expands the web of construct validation of the eight scales. Investigators now have a 
reference point for selecting scales and understanding the expected correlations when using 
multiple scales.
Limitations
Although this study demonstrates the broad usefulness of PROMIS pediatric measures 
across several chronic illnesses, there are important limitations to the conclusions we can 
draw. Most importantly, the samples were not drawn to be broadly representative of the 
disease category and we specifically oversampled specific subcategories of disease (e.g., 
children with nephrotic syndrome and specific types of cancer). Because of this approach, 
we cannot assume that the mean level of functioning or symptom for a disease category 
would represent the population with that disease. For this reason, we are not able to provide 
a mean and distribution of scores that represent the disease categories broadly (e.g., the 
population of sickle cell disease has a mean score of X). This study does provide evidence 
that differences within disease by severity of illness are likely more important than average 
PRO scores for a general category of disease. This effect may also reflect that many patients 
with a chronic illness have other comorbidities that can affect PROs. Although this makes it 
difficult to attribute symptoms or quality of life to one illness, it does capture what is 
important to patients, which is how they feel and function regardless of the cause. It is also 
possible that in some of the populations, our tests are comparisons between moderate 
severity and high severity without an adequate test of mild severity compared with moderate 
severity. Larger population based samples may help to establish more refined categories.
These data collections were conducted to meet a variety of needs for further development of 
PROMIS measures. As such, not all participants in each group completed every 
questionnaire. Fortunately, our design randomly allocated some questionnaires within a 
disease group. For this reason, we believe the estimated scores should reflect the whole 
enrolled population. Additionally, this is a cross-sectional study and differences across 
groups do not represent a measurement of change.
In conclusion, the present findings provide support for the measurement properties of these 
PROMIS pediatric self-report scales in the chronic health conditions studied. Specifically, 
this data provides preliminary evidence of known-groups validity (that is the ability to 
discriminate PRO scores between different clinically meaningful subgroups of individual 
diseases). Using measurement scales like PROMIS can provide comparable and nuanced 
views into the health experience of children across chronic illnesses. Further research is 
needed to determine the responsiveness of the PROMIS pediatric scales to change over time 
in the chronic health conditions studied and across other pediatric chronic health conditions. 
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In addition, data on a nationally representative healthy or general pediatric population are 
necessary to give greater meaning to the standardized scores utilized in future PROMIS 
pediatric comparison studies.
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Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
PROMIS® was funded with cooperative agreements from the National Institutes of Health (NIH) Common Fund 
Initiative (Northwestern University, PI: David Cella, PhD, U54AR057951, U01AR052177; Northwestern 
University, PI: Richard C. Gershon, PhD, U54AR057943; American Institutes for Research, PI: Susan (San) D. 
Keller, PhD, U54AR057926; State University of New York, Stony Brook, PIs: Joan E. Broderick, PhD and Arthur 
A. Stone, PhD, U01AR057948, U01AR052170; University of Washington, Seattle, PIs: Heidi M. Crane, MD, 
MPH, Paul K. Crane, MD, MPH, and Donald L. Patrick, PhD, U01AR057954; University of Washington, Seattle, 
PI: Dagmar Amtmann, PhD, U01AR052171; University of North Carolina, Chapel Hill, PI: Harry A. Guess, MD, 
PhD (deceased), Darren A. DeWalt, MD, MPH, U01AR052181; Children's Hospital of Philadelphia, PI: 
Christopher B. Forrest, MD, PhD, U01AR057956; Stanford University, PI: James F. Fries, MD, U01AR052158; 
Boston University, PIs: Alan Jette, PT, PhD, Stephen M. Haley, PhD (deceased), and David Scott Tulsky, PhD 
(University of Michigan, Ann Arbor), U01AR057929; University of California, Los Angeles, PIs: Dinesh Khanna, 
MD (University of Michigan, Ann Arbor) and Brennan Spiegel, MD, MSHS, U01AR057936; University of 
Pittsburgh, PI: Paul A. Pilkonis, PhD, U01AR052155; Georgetown University, PIs: Carol. M. Moinpour, PhD 
(Fred Hutchinson Cancer Research Center, Seattle) and Arnold L. Potosky, PhD, U01AR057971; Children's 
Hospital Medical Center, Cincinnati, PI: Esi M. Morgan DeWitt, MD, MSCE, U01AR057940; University of 
Maryland, Baltimore, PI: Lisa M. Shulman, MD, U01AR057967; and Duke University, PI: Kevin P. Weinfurt, 
PhD, U01AR052186). NIH Science Officers on this project have included Deborah Ader, PhD, Vanessa Ameen, 
MD (deceased), Susan Czajkowski, PhD, Basil Eldadah, MD, PhD, Lawrence Fine, MD, DrPH, Lawrence Fox, 
MD, PhD, Lynne Haverkos, MD, MPH, Thomas Hilton, PhD, Laura Lee Johnson, PhD, Michael Kozak, PhD, Peter 
Lyster, PhD, Donald Mattison, MD, Claudia Moy, PhD, Louis Quatrano, PhD, Bryce Reeve, PhD, William Riley, 
PhD, Peter Scheidt, MD, Ashley Wilder Smith, PhD, MPH, Susana Serrate-Sztein, MD, William Phillip Tonkins, 
DrPH, Ellen Werner, PhD, Tisha Wiley, PhD, and James Witter, MD, PhD. The contents of this article uses data 
developed under PROMIS. These contents do not necessarily represent an endorsement by the US Federal 
Government or PROMIS. See www.nihpromis.org for additional information on the PROMIS® initiative.
References
1. Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, Ader DN, Fries JF, Bruce B, Rose M. 
The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH 
Roadmap Cooperative Group during its first two years. Medical Care. 2007; 45(Suppl 1):S3–S11. 
[PubMed: 17443116] 
2. Irwin DE, Stucky BD, Thissen D, DeWitt EM, Lai JS, Yeatts K, Varni JW, DeWalt DA. Sampling 
plan and patient characteristics of the PROMIS pediatrics large-scale survey. Quality of Life 
Research. 2010; 19:585–594. [PubMed: 20204706] 
3. Irwin DE, Stucky BD, Langer MM, Thissen D, DeWitt EM, Lai JS, Varni JW, Yeatts K, DeWalt 
DA. An item response analysis of the pediatric PROMIS anxiety and depressive symptoms scales. 
Quality of Life Research. 2010; 19:595–607. [PubMed: 20213516] 
4. Varni JW, Stucky BD, Thissen D, DeWitt EM, Irwin DE, Lai JS, Yeatts K, DeWalt DA. PROMIS 
Pediatric Pain Interference Scale: An item response theory analysis of the pediatric pain item bank. 
Journal of Pain. 2010; 11:1109–1119. [PubMed: 20627819] 
5. DeWitt EM, Stucky BD, Thissen D, Irwin DE, Langer M, Varni JW, Lai JS, Yeatts KB, DeWalt 
DA. Construction of the eight-item patient-reported outcomes measurement information system 
pediatric physical function scales: Built using item response theory. Journal of Clinical 
Epidemiology. 2011; 64:794–804. [PubMed: 21292444] 
6. Irwin DE, Stucky BD, Langer MM, Thissen D, DeWitt EM, Lai JS, Yeatts KB, Varni JW, DeWalt 
DA. PROMIS Pediatric Anger Scale: An item response theory analysis. Quality of Life Research. 
2012; 21:697–706. [PubMed: 21785833] 
DeWalt et al. Page 12













7. DeWalt DA, Thissen D, Stucky BD, Langer MM, DeWitt EM, Irwin DE, Lai JS, Yeatts KB, Gross 
HE, Taylor O, Varni JW. PROMIS Pediatric Peer Relationships Scale: Development of a peer 
relationships item bank as part of social health measurement. Health Psychology. in press. 
8. Lai JS, Stucky BD, Thissen D, Varni JW, DeWitt EM, Irwin DE, Yeatts KB, Dewalt DA. 
Development and psychometric properties of the PROMIS® pediatric fatigue item banks. Quality 
of Life Research. in press. 
9. Walsh TR, Irwin DE, Meier A, Varni JW, DeWalt DA. The use of focus groups in the development 
of the PROMIS pediatrics item bank. Quality of Life Research. 2008; 17:725–735. [PubMed: 
18427951] 
10. Irwin DE, Varni JW, Yeatts K, DeWalt DA. Cognitive interviewing methodology in the 
development of a pediatric item bank: a patient reported outcomes measurement information 
system (PROMIS) study. Health and Quality of Life Outcomes. 2009; 7:3. 1-10. [PubMed: 
19166601] 
11. Reise SP, Waller NG. Item response theory and clinical measurement. Annual Review of Clinical 
Psychology. 2009; 5:27–48.
12. Embretson, SE.; Reise, SP. Item Response Theory for Psychologists. Mahwah, NJ: Erlbaum; 2000. 
13. Varni JW, Limbers CA, Burwinkle TM. Impaired health-related quality of life in children and 
adolescents with chronic conditions: A comparative analysis of 10 disease clusters and 33 disease 
categories/severities utilizing the PedsQL™ 4.0 Generic Core Scales. Health and Quality of Life 
Outcomes. 2007; 5:43. 1-15. [PubMed: 17634123] 
14. Dampier C, Lieff S, LeBeau P, Rhee S, McMurray M, Rogers Z, Smith-Whitley K, Wang W. 
Comprehensive Sickle Cell Centers Clinical Trial, C. Health-related quality of life in children with 
sickle cell disease: a report from the Comprehensive Sickle Cell Centers Clinical Trial 
Consortium. Pediatr Blood Cancer. 2010; 55(3):485–494. [PubMed: 20658620] 
15. Sung L, Klaassen RJ, Dix D, Pritchard S, Yanofsky R, Dzolganovski B, Almeida R, Klassen A. 
Identification of paediatric cancer patients with poor quality of life. Br J Cancer. 2009; 100(1):82–
88. [PubMed: 19066605] 
16. Weissberg-Benchell J, Nansel T, Holmbeck G, Chen R, Anderson B, Wysocki T, Laffel L. 
Steering Committee of the Family Management of Diabetes, S. Generic and diabetes-specific 
parent-child behaviors and quality of life among youth with type 1 diabetes. J Pediatr Psychol. 
2009; 34(9):977–988. [PubMed: 19270028] 
17. Gerson AC, Wentz A, Abraham AG, Mendley SR, Hooper SR, Butler RW, Gipson DS, Lande 
MB, Shinnar S, Moxey-Mims MM, Warady BA, Furth SL. Health-related quality of life of 
children with mild to moderate chronic kidney disease. Pediatrics. 2010; 125(2):e349–357. 
[PubMed: 20083528] 
18. Tsiros MD, Olds T, Buckley JD, Grimshaw P, Brennan L, Walkley J, Hills AP, Howe PR, Coates 
AM. Health-related quality of life in obese children and adolescents. Int J Obes (Lond). 2009; 
33(4):387–400. [PubMed: 19255583] 
19. Hinds PS, Nuss SL, Ruccione KS, Withycombe JS, Jacobs S, Deluca H, Faulkner C, Liu Y, Cheng 
YI, Gross HE, Wang J, Dewalt DA. PROMIS pediatric measures in pediatric oncology: Valid and 
clinically feasible indicators of patient-reported outcomes. Pediatric blood & cancer. 2013; 60(3):
402–408. [PubMed: 22829446] 
20. Gipson DS, Selewski DT, Massengill SF, Wickman L, Messer KL, Herreshoff E, Bowers C, Ferris 
ME, Mahan JD, Greenbaum LA, MacHardy J, Kapur G, Chand DH, Goebel J, Barletta GM, Geary 
D, Kershaw DB, Pan CG, Gbadegesin R, Hidalgo G, Lane JC, Leiser JD, Plattner BW, Song PX, 
Thissen D, Liu Y, Gross HE, DeWalt DA. Gaining the PROMIS perspective from children with 
nephrotic syndrome: a Midwest pediatric nephrology consortium study. Health and quality of life 
outcomes. 2013; 11:30. [PubMed: 23510630] 
21. Selewski DT, Collier DN, MacHardy J, Gross HE, Pickens EM, Cooper AW, Bullock S, Earls MF, 
Pratt KJ, Scanlon K, McNeill JD, Messer KL, Lu Y, Thissen D, DeWalt DA, Gipson DS. 
Promising insights into the health related quality of life for children with severe obesity. Health 
and quality of life outcomes. 2013; 11:29. [PubMed: 23452863] 
22. Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, Rosenzweig JC, Manjunath R. 
Development and cross-sectional validation of the childhood asthma control test. Journal of 
Allergy and Clinical Immunology. 2007; 119:817–825. [PubMed: 17353040] 
DeWalt et al. Page 13













23. Menard JC, Hinds PS, Jacobs SS, Cranston K, Wang J, DeWalt DA, Gross HE. Feasibility and 
acceptability of the patient-reported outcomes measurement information system measures in 
children and adolescents in active cancer treatment and survivorship. Cancer Nurs. 2014; 37(1):
66–74. [PubMed: 24036439] 
24. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A. A simple estimate of glomerular filtration 
rate in children derived from body length and plasma creatinine. Pediatrics. 1976; 58:259–263. 
[PubMed: 951142] 
25. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with 
juvenile rheumatoid arthritis. Arthritis and Rheumatism. 1994; 37:1761–1769. [PubMed: 7986222] 
26. Reeve BB, Hays RD, Bjorner JB, Cook KF, Crane PK, Teresi JA, Thissen D, Revicki DA, Weiss 
DL, Hambleton RK, Lui H, Gershon R, Reise SP, Lai JS, Cella D. Psychometric evaluation and 
calibration of health-related quality of life item banks: Plans for the Patient-Report Outcomes 
Measurement Information System (PROMIS). Medical Care. 2007; 45(Suppl 1):S22–S31. 
[PubMed: 17443115] 
27. Cai L. Metropolis-Hastings Robbins-Monro algorithm for confirmatory item factor analysis. 
Journal of Educational and Behavioral Statistics. 2010; 35:307–335.
28. Cai, L.; Thissen, D.; du Toit, SHC. IRTPRO for Windows. Lincolnwood, IL: Scientific Software 
International; 2011. Computer software
29. Everhart RS, Fiese BH. Asthma severity and child quality of life in pediatric asthma: A systematic 
review. Patient Education and Counseling. 2009; 75:162–168. [PubMed: 19036553] 
30. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life 
in children with asthma. Quality of Life Research. 1996; 5:35–46. [PubMed: 8901365] 
31. Ji Y, Chen S, Li K, Xiao N, Yang X, Zheng S, Xiao X. Measuring health-related quality of life in 
children with cancer living in mainland China: Feasibility, reliability and validity of the Chinese 
Mandarin version of PedsQL 4.0 Generic Core Scales and 3.0 Cancer Module. Health and Quality 
of Life Outcomes. 2011; 9:103. [PubMed: 22111968] 
32. Bhatia S, Jenney MEM, Wu E, Bogue MK, Rockwood TH, Feusner JH, Friedman DL, Robison 
LL, Kane RL. The Minneapolis-Manchester Quality of Life Instrument: Reliability and validity of 
the youth form. Journal of Pediatrics. 2004; 145:39–46. [PubMed: 15238904] 
33. Eiser C, Hill JJ, Vance YH. Examining the psychological consequences of surviving childhood 
cancer: Systematic review as a research method in pediatric psychology. Journal of Pediatric 
Psychology. 2000; 25:449–460. [PubMed: 10980049] 
34. Zeltzer LK, Lu Q, Leisenring W, Tsao JC, Recklitis C, Armstrong G, Mertens AC, Robison LL, 
Ness KK. Psychosocial outcomes and health-related quality of life in adult childhood cancer 
survivors: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev. 
2008; 17(2):435–446. [PubMed: 18268128] 
35. Zebrack BJ, Chesler MA. Quality of life in childhood cancer survivors. Psychooncology. 2002; 
11(2):132–141. [PubMed: 11921329] 
36. Gerson AC, Wentz A, Abraham AG, Mendley SR, Hooper SR, Butler RW, Gipson DS, Lande 
MB, Shinnar S, Moxey-Mims MM, Warady BA, Furth SL. Health-related quality of life of 
children with mild to moderate chronic kidney disease. Pediatrics. 2010; 125:e349–357. [PubMed: 
20083528] 
37. Heath J, Mackinlay D, Watson AR, Hames A, Wirz L, Scott S, Klewchuk E, Milford D, McHugh 
K. Self-reported quality of life in children and young people with chronic kidney disease. Pediatric 
Nephrology. 2011; 26:767–773. [PubMed: 21327779] 
38. Schwimmer JB, Burwinkle TM, Varni JW. Health-related quality of life of severely obese children 
and adolescents. JAMA. 2003; 289:1813–1819. [PubMed: 12684360] 
39. Williams J, Wake M, Hesketh K, Maher E, Waters E. Health-related quality of life of overweight 
and obese children. JAMA. 2005; 293:70–76. [PubMed: 15632338] 
40. Varni JW, Limbers CA, Bryant WP, Wilson DP. The PedsQL™ Multidimensional Fatigue Scale in 
pediatric obesity: Feasibility, reliability, and validity. International Journal of Pediatric Obesity. 
2010; 5:34–42. [PubMed: 19593727] 
41. Ul-Haq Z, Mackay DF, Fenwick E, Pell JP. Meta-analysis of the association between body mass 
index and health-related quality of life among children and adolescents, assessed using the 
DeWalt et al. Page 14













Pediatric Quality of Life Inventory Index. Journal of Pediatrics. 2013; 162:280–286. [PubMed: 
22959137] 
42. Varni JW, Seid M, Knight TS, Burwinkle TM, Brown J, Szer IS. The PedsQL™ in pediatric 
rheumatology: Reliability, validity, and responsiveness of the Pediatric Quality of Life 
Inventory™ Generic Core Scales and Rheumatology Module. Arthritis and Rheumatism. 2002; 
46:714–725. [PubMed: 11920407] 
43. Seid M, Opipari L, Huange B, Brunner HI, Lovell DJ. Disease control and health-related quality of 
life in juvenile idiopathic arthritis. Arthritis and Rheumatism. 2009; 61:393–399. [PubMed: 
19248113] 
44. Ringold S, Wallace CA, Rivara FP. Health-related quality of life, physical function, fatigue, and 
disease activity in children with established polyarticular juvenile idiopathic arthritis. Journal of 
Rheumatology. 2009; 36:1330–1336. [PubMed: 19411394] 
45. Dampier C, Lieff S, Lebeau P, Rhee S, McMurray M, Rogers Z, Smith-Whitley K, Wang W. 
Health-related quality of life in children with sickle cell disease: A report from the Comprehensive 
Sickle Cell Centers Clinical Trial Consortium. Pediatric Blood & Cancer. 2010; 55:485–494. 
[PubMed: 20658620] 
Abbreviations
PROMIS® Patient Reported Outcomes Measurement Information System
NIH National Institutes of Health
DeWalt et al. Page 15
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































DeWalt et al. Page 20
Table 3
Comparison of PROMIS scores for children hospitalized at least once in the past 6 months with those not 
hospitalized, pooling sickle cell disease, cancer, kidney disease, and rheumatic disease.
Child has been hospitalized one or more times N Mean (SD) T Statistic
Mobility 0 (No) 759 51 (9) 7.53***
1 (Yes) 284 46 (10)
Upper Extremity 0 813 51 (8) 4.05***
1 311 49 (8)
Peer Relationships 0 588 51 (10) 3.98***
1 269 47 (11)
Depressive Symptoms 0 630 46 (10) 2.79**
1 295 48 (11)
Anxiety 0 587 45 (11) 3.20**
1 267 48 (12)
Anger 0 172 47 (12) 0.24
1 65 47 (11)
Pain Interference 0 679 45 (11) 6.08***
1 256 51 (12)
Fatigue 0 623 44 (12) 5.81***








Values in the parentheses are standard deviations.




















































































































































































































































Qual Life Res. Author manuscript; available in PMC 2016 September 01.
